Filter Results:
(973)
Show Results For
- All HBS Web
(1,928)
- People (5)
- News (489)
- Research (973)
- Events (10)
- Multimedia (13)
- Faculty Publications (508)
Show Results For
- All HBS Web
(1,928)
- People (5)
- News (489)
- Research (973)
- Events (10)
- Multimedia (13)
- Faculty Publications (508)
Sort by
- 23 Jan 2024
- Book
More Than Memes: NFTs Could Be the Next Gen Deed for a Digital World
they’re embedded in software, many NFTs can take on functions over and above simple ownership. Owning a house might also gain you access to the local Rotary Club and public schools. Imagine that but for brands: owning a Nike SWOOSH NFT... View Details
- 02 Aug 2016
- First Look
August 2, 2016
forthcoming Organizational Behavior and Human Decision Processes Don't Stop Believing: Rituals Improve Performance by Decreasing Anxiety By: Brooks, Alison Wood, Julianna Schroeder, Jane Risen, Francesca Gino, Adam D. Galinsky, Michael I. Norton, and Maurice Schweitzer... View Details
Keywords: Sean Silverthorne
- 16 Feb 2023
- HBS Case
ESG Activists Met the Moment at ExxonMobil, But Did They Succeed?
The impact-investment hedge fund Engine No. 1 made a big splash in May 2021 when it managed to get three nominees elected to the ExxonMobil board of directors. It was an open effort to prod the oil giant toward renewable energy and test whether activist investing could... View Details
- 01 Nov 2020
- Research & Ideas
Good Leadership Is an Act of Kindness
in fear of losing their jobs. In times of crisis, bosses must alter their expectations. As Bryce Covert wrote in a New York Times op-ed, "Keeping output steady while maintaining our physical and mental health just cannot be done. We have... View Details
Keywords: by Boris Groysberg and Susan Seligson
- 04 Sep 2001
- Research & Ideas
Is Government Just Stupid? How Bad Decisions Are Made
evaluating business leaders, most people judge them primarily by results: profitability, return to shareholders, innovation and so on. This is the more rational measure of effectiveness. An organization's overall health will generally... View Details
- 13 Dec 2016
- First Look
December 13, 2016
fundamental firm value, which is gradually revealed into prices. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=51971 December 2016 Harvard Business Review Health Care Needs Real Competition By: Dafny, Leemore S., and... View Details
Keywords: Carmen Nobel
- 02 Jun 2022
- Research & Ideas
Blissful Thinking: When It Comes to Finding Happiness, 'Your Dreams Are Liars'
seen it with the inception of the Center for Health and Happiness at the Harvard T.H. Chan School of Public Health. And, really, the interest is global. What do you think is behind this rise in scholarly... View Details
Keywords: by Dan Morrell
- 24 Feb 2022
- Op-Ed
Want to Prevent the Next Hospital Bed Crisis? Enlist the SEC
billing rule that hospitals had ignored, it imposed a tangle of new requirements and directed the US Department of Health and Human Services (HHS) to help prevent excess out-of-network charges. And consider the HHS’s multimillion dollar... View Details
- 06 Mar 2007
- First Look
First Look: March 6, 2007
understand why some of the other top firms in the business, such as KKR and Apollo, have been tapping the public equity markets for their own funds, and whether they should do the same. They are also pondering how to monetize their own... View Details
Keywords: Martha Lagace
- 04 Apr 2017
- First Look
First Look at New Research, April 4
of its primary holding, Fullerton Health, was deeply involved in preparations for taking Fullerton public on the Singapore stock exchange. Three years after SIN Capital had invested in Fullerton—a provider of enterprise View Details
Keywords: Sean Silverthorne
- 13 Feb 2018
- First Look
New Research and Ideas, February 13, 2018
and industrial designs used by firms to protect their IP globally. We then show that IP protection remains fragmented, the quality of IP applications might be questionable, and the development of a comprehensive IP footprint worldwide is... View Details
Keywords: Sean Silverthorne
- June 2020
- Article
Waiting to Inhale: Reducing Stigma in the Medical Cannabis Industry
By: Kisha Lashley and Timothy G. Pollock
When a new industry category is predicated on a product or activity subject to ‘‘core’’ stigma—meaning its very nature is stigmatized—the actors trying to establish it may struggle to gain the resources they need to survive and grow. To explain the process of reducing... View Details
Keywords: Stigma; Cannabis Industry; Deviance; Public Opinion; Moral Sensibility; Health Care and Treatment
Lashley, Kisha, and Timothy G. Pollock. "Waiting to Inhale: Reducing Stigma in the Medical Cannabis Industry." Administrative Science Quarterly 65, no. 2 (June 2020): 434–482.
- 18 Jul 2023
- Research & Ideas
Will Global Demand for Oil Peak This Decade?
Is the globe’s thirst for oil finally topping out? A major international energy watcher says yes, predicting last month that demand for global oil for transport will peak around 2026, plateau for all uses by 2028, and possibly hit a zenith by the end of the decade.... View Details
- 2017
- White Paper
Medical Knowledge Synthesis: A Brief Overview
By: Maryaline Catillon
The value of medical research derives from its ability to impact further research and medical practice. Medical knowledge synthesis, bridging the gap between current research, future research and medical practice, is a rapidly changing industry. The expanding mass of... View Details
Keywords: Systematic Review; Clinical Practice Guideline; Textbook; Point-of-care Resource; Health; Knowledge; Research; Practice; Health Industry
Catillon, Maryaline. "Medical Knowledge Synthesis: A Brief Overview." White Paper, National Bureau of Economic Research, 2017.
- 11 Mar 2008
- First Look
First Look: March 11, 2008
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=808104 Partners in Health: The PACT Project Harvard Business School Case 608-065 Partners in Health (PIH) is a Boston-based, not-for-profit that provides View Details
Keywords: Martha Lagace
- November 2017
- Case
The 'Wonder Drug' That Killed Babies
By: Joshua Lev Krieger, Tom Nicholas and Matthew Preble
In the early 1960s, a popular drug taken by patients worldwide for a range of maladies was found to cause severe birth defects and other health problems in babies born to mothers who had taken it during a certain stage of fetal development. As many as 10,000 children... View Details
Keywords: Regulation; Business and Government Relations; Business and Community Relations; Business and Stakeholder Relations; Product Marketing; Corporate Social Responsibility and Impact; Business History; Health; Government Legislation; Corporate Accountability; Ethics; Governing Rules, Regulations, and Reforms; Public Administration Industry; Public Administration Industry; United States; United Kingdom; Australia; Germany; Europe
Krieger, Joshua Lev, Tom Nicholas, and Matthew Preble. "The 'Wonder Drug' That Killed Babies." Harvard Business School Case 818-044, November 2017.
- March 2024
- Article
Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act
By: Matthew Vogel, Pragya Kakani, Amitabh Chandra and Rena M. Conti
The Inflation Reduction Act (IRA) requires Medicare to negotiate lower prices for some medicines with high Medicare spending. Using historical data from public and proprietary sources to apply the IRA's negotiation criteria retrospectively, we identify all drugs that... View Details
Keywords: Policy; Government Legislation; Health Care and Treatment; Negotiation; Price; Pharmaceutical Industry
Vogel, Matthew, Pragya Kakani, Amitabh Chandra, and Rena M. Conti. "Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act." Nature Biotechnology 42, no. 3 (March 2024): 406–412.
- January–February 2021
- Article
Food and Drug Administration Guidance Documents and New Medical Devices: The Case of Breast Prostheses
By: Rachel E. Weitzman, Ariel Dora Stern and Daniel B. Kramer
As pressure mounts on the Food and Drug Administration (FDA) to speed its review process for novel devices, and budgetary pressures further strain its resources, the critical role of guidance documents in assuring consistent, rigorous, and scientifically grounded... View Details
Keywords: Medical Devices; FDA; Health Care and Treatment; Government Administration; Information; Standards
Weitzman, Rachel E., Ariel Dora Stern, and Daniel B. Kramer. "Food and Drug Administration Guidance Documents and New Medical Devices: The Case of Breast Prostheses." American Journal of Therapeutics 28, no. 1 (January–February 2021).
- 18 Nov 2008
- First Look
First Look: November 18, 2008
for compensation committees at public companies. Purchase this case: http://harvardbusinessonline.hbsp.harvard.edu/ b01/en/common/item_detail.jhtml?id=109036 Hearts on Fire—Brand Development Manager Harvard Business School Case 709-436... View Details
Keywords: Martha Lagace
- 01 Oct 2021
- Research & Ideas
Dying to Lead: How Reaching the Top Can Kill You Sooner
Business Administration. The detrimental health impacts of pressure-filled professions are increasingly getting the attention of business leaders, who are not only concerned about the welfare of their workers, but also have an eye on... View Details
Keywords: by Jay Fitzgerald